Trimetazidine 35mg 60 tablets

Composition:
active ingredient: trimetazidine; 1 tablet contains trimetazidine dihydrochloride 35 mg;
excipients: corn starch, mannitol (E 421), povidone, talc, magnesium stearate, Opadry II Red shell coating (talc, polyethylene glycol, indigo (E 132), polyvinyl alcohol, titanium dioxide (E 171), Ponceau 4R ( E 124), “yellow sunset” (E110).

Indications

For the symptomatic treatment of adult patients with stable angina who have failed or are intolerant of first-line antianginal drugs.

Dosage & Administration

Triductan designate the interior of 1 tablet 3 times a day with meals.
Triductan is designate for the interior of 1 tablet 2 times a day, morning and evening during meals, washed down with a glass of water. The drug is intended for long-term use. If necessary, a treatment plan can be reviewed after 3 months.
Duration of treatment is determined individually.

Contradictions

Increased individual sensitivity to the drug.